SOAT1 and myeloproliferative neoplasm: More than a decade on from the original description of JAK2 V617F, it seems that contributing the MPN phenotype to constitutive activation of JAK2 is to over simplify the complex molecular interactions that regulate the JAK/STAT pathway.